Status:
COMPLETED
BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Gynecologic Cancer
Gastrointestinal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study is evaluating a new intervention, BOLSTER, which was designed to provide more support for patients with gynecologic and gastrointestinal cancers and their caregivers after a hospit...
Detailed Description
Hospitalizations can be difficult for patients with cancer, especially when they are transitioning home. Patients and caregivers are often expected to perform complex medical and nursing tasks with li...
Eligibility Criteria
Inclusion
- Patient inclusion criteria
- Adults (≥18 years old);
- GYN or GI cancers receiving anti-neoplastic therapy;
- Hospitalized, recently hospitalized (i.e. within the first 2 visits after a hospitalization), or recent outpatient placement of tube, line, or drain (e.g. PleurX catheter);
- Plan to receive ongoing care at DFCI;
- Willingness to be audio taped for the study (for monitoring of study fidelity).
- Have complex care needs (e.g. an ostomy, ileostomy, a gastric tube, percutaneous nephrostomy tubes, a PleurX catheter, or need for total parenteral nutrition)
- Patient exclusion criteria
- Unable to read and respond to questions in English;
- Cognitive impairment;
- Unable to complete the baseline interview;
- Plan for immediate hospice referral
- Caregiver inclusion criteria
- Adults (≥18 years old);
- Family member or friend of an eligible patient;
- Willingness to be audio taped for the study (for monitoring of study fidelity);
- Willingness to participate in study visits
- Caregiver exclusion criteria:
- Unable to read and respond to questions in English,
- Cognitive impairment
- Unable to complete the baseline interview
Exclusion
Key Trial Info
Start Date :
April 24 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 27 2023
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT03367247
Start Date
April 24 2018
End Date
July 27 2023
Last Update
October 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
25873
Boston, Massachusetts, United States, 02215